PL1732557T3 - Pochodne 1-[2H-1-benzopiran-2-on-8-ylo]-piperazyny do leczenia zaburzeń ruchowych - Google Patents

Pochodne 1-[2H-1-benzopiran-2-on-8-ylo]-piperazyny do leczenia zaburzeń ruchowych

Info

Publication number
PL1732557T3
PL1732557T3 PL05717127T PL05717127T PL1732557T3 PL 1732557 T3 PL1732557 T3 PL 1732557T3 PL 05717127 T PL05717127 T PL 05717127T PL 05717127 T PL05717127 T PL 05717127T PL 1732557 T3 PL1732557 T3 PL 1732557T3
Authority
PL
Poland
Prior art keywords
benzopyran
treatment
movement disorders
piperazine derivatives
piperazine
Prior art date
Application number
PL05717127T
Other languages
English (en)
Inventor
Cornelis; Bakker
Jeffrey C ; Glennon
Mayke B ; Hesselink
Claudia; Thaete
Andrew; Mccreary
Scharrenburg Gustaaf J ; Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of PL1732557T3 publication Critical patent/PL1732557T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
PL05717127T 2004-03-25 2005-03-23 Pochodne 1-[2H-1-benzopiran-2-on-8-ylo]-piperazyny do leczenia zaburzeń ruchowych PL1732557T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55595904P 2004-03-25 2004-03-25
EP04101229 2004-03-25
PCT/EP2005/051327 WO2005092339A1 (en) 2004-03-25 2005-03-23 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
EP05717127A EP1732557B1 (en) 2004-03-25 2005-03-23 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders

Publications (1)

Publication Number Publication Date
PL1732557T3 true PL1732557T3 (pl) 2010-03-31

Family

ID=34928927

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05717127T PL1732557T3 (pl) 2004-03-25 2005-03-23 Pochodne 1-[2H-1-benzopiran-2-on-8-ylo]-piperazyny do leczenia zaburzeń ruchowych

Country Status (11)

Country Link
US (1) US20050215551A1 (pl)
EP (1) EP1732557B1 (pl)
JP (1) JP2007530508A (pl)
AR (1) AR048111A1 (pl)
AT (1) ATE446757T1 (pl)
CA (1) CA2554073A1 (pl)
ES (1) ES2335222T3 (pl)
PL (1) PL1732557T3 (pl)
SA (1) SA05260060B1 (pl)
TW (1) TWI340643B (pl)
WO (1) WO2005092339A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR049478A1 (es) * 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
US20060013874A1 (en) * 2004-07-15 2006-01-19 Solvay Pharmaceuticals B.V. Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
CN113907770B (zh) * 2021-10-21 2023-05-09 中国电子科技集团公司第三十八研究所 基于特征融合的棘慢复合波检测识别方法及系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
CA2126554A1 (en) * 1992-01-07 1993-07-22 Martin Galvan Treatment of involuntary movements with 5ht1a receptor agonists
EP0650964A1 (en) 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
CN1100055C (zh) * 1996-03-29 2003-01-29 杜菲尔国际开发有限公司 哌嗪和哌啶化合物
US6376494B1 (en) * 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
JP2004231514A (ja) * 2000-08-31 2004-08-19 Meiji Seika Kaisha Ltd ５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
AU2003226751A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts

Also Published As

Publication number Publication date
ATE446757T1 (de) 2009-11-15
WO2005092339A1 (en) 2005-10-06
US20050215551A1 (en) 2005-09-29
ES2335222T3 (es) 2010-03-23
EP1732557A1 (en) 2006-12-20
TWI340643B (en) 2011-04-21
AR048111A1 (es) 2006-03-29
CA2554073A1 (en) 2005-10-06
SA05260060A (ar) 2005-12-03
EP1732557B1 (en) 2009-10-28
JP2007530508A (ja) 2007-11-01
SA05260060B1 (ar) 2009-04-18
TW200534848A (en) 2005-11-01

Similar Documents

Publication Publication Date Title
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1833467A4 (en) PHARMACEUTICAL COMPOSITIONS FOR SLEEP DISORDERS
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
TWI369987B (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
IL191283A (en) Compositions for treating eye irregularities
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL182906A0 (en) Method for treatment of movement disorders
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
SI1907374T1 (sl) Derivati benzilpiperazina uporabni za zdravljenje gastrointestinalnih motenj
IL186049A0 (en) Prophylactic or therapeutic agent for depression or anxiety disorders
TWI350753B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
TWI340643B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
PL1727545T3 (pl) Zastosowanie pochodnych N-piperydyny do leczenia patologii neurodegeneracyjnych
GB0400802D0 (en) Compounds for the treatment of disease
ZA200606780B (en) Compounds for the treatment of diseases
EP1681063A4 (en) MEDIUM TO IMPROVE MENTAL DISEASES
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases
IL176564A0 (en) Sulfonamide derivatives for the treatment of diseases